PARP-inhibition reprograms macrophages toward an anti-tumor phenotype | Zendy

Lin Wang | Zendy; Dan Wang | Zendy; Olmo Sonzogni | Zendy; Shizhong Ke | Zendy; Qi Wang | Zendy; Abhishek Thavamani | Zendy; Felipe Batalini | Zendy; Sylwia A. Stopka | Zendy; Michael S. Regan | Zendy; Steven Vandal | Zendy; Shengya Tian | Zendy; Jocelin Pinto | Zendy; Andrew M. Cyr | Zendy; Vanessa C. Bret-Mounet | Zendy; Gerard Baquer | Zendy; Hans Petter Eikesdal | Zendy; Min Yuan | Zendy; John M. Asara | Zendy; Yujing J. Heng | Zendy; Péter Bai | Zendy; Nathalie Y.R. Agar | Zendy; Gerburg M. Wulf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

Author(s) -

Lin Wang,

Dan Wang,

Olmo Sonzogni,

Shizhong Ke,

Qi Wang,

Abhishek Thavamani,

Felipe Batalini,

Sylwia A. Stopka,

Michael S. Regan,

Steven Vandal,

Shengya Tian,

Jocelin Pinto,

Andrew M. Cyr,

Vanessa C. Bret-Mounet,

Gerard Baquer,

Hans Petter Eikesdal,

Min Yuan,

John M. Asara,

Yujing J. Heng,

Péter Bai,

Nathalie Y.R. Agar,

Gerburg M. Wulf

Publication year - 2022

Publication title -

cell reports

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2022.111462

Subject(s) - olaparib , cancer research , poly adp ribose polymerase , parp1 , reprogramming , nad+ kinase , tumor microenvironment , parp inhibitor , ex vivo , biology , cancer cell , chemistry , in vivo , microbiology and biotechnology , cancer , biochemistry , cell , polymerase , genetics , gene , tumor cells , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research